We further investigated tumor-infiltrated immune cells in the tumor microenvironment, and found a significant increase of CD45+ cells, and CD8+ T cells but not CD4+ T cells in the tumor tissues after β-lap treatment (Supplementary Fig. 3b). The gene discussed is CD4; the disease is neoplasm.